Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cancer drug combo shows promise in early trials

NCT ID NCT05751798

Recruiting now Disease control Sponsor: OSE Immunotherapeutics Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new immunotherapy drug called OSE-279, both alone and in combination with another drug, for people with advanced solid tumors or lymphomas. The trial aims to find safe doses and see if these treatments can help control cancer growth. It's specifically looking at patients with advanced non-small cell lung cancer who haven't had prior treatment for their metastatic disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Antwerp University Hospital

    NOT_YET_RECRUITING

    Edegem, 11013, Belgium

  • Centre Eugène Marquis

    COMPLETED

    Rennes, 35000, France

  • Centre Léon Bérard

    RECRUITING

    Lyon, 69373, France

  • Hopital Saint Joseph

    RECRUITING

    Paris, 75014, France

  • Hospital Regional Universitario de Málaga

    RECRUITING

    Málaga, 2901, Spain

  • Institut Gustave Roussy

    RECRUITING

    Villejuif, 94805, France

  • Institut Jules Bordet

    RECRUITING

    Anderlecht, 1070, Belgium

  • Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta (IDIBGI)

    RECRUITING

    Girona, 17007, Spain

  • Institut de Cancerologie de l'Ouest

    RECRUITING

    Saint-Herblain, 44805, France

  • Oncopole

    RECRUITING

    Toulouse, 31059, France

  • University Hospital A Coruña Biomedical Research Institute (INIBIC)

    RECRUITING

    A Coruña, Spain

Conditions

Explore the condition pages connected to this study.

LYMPHOMA NSCLC NON-SMALL CELL LUNG CANCER SOLID ADVANCED TUMOR